Does Impaired Processing of Pro-B-type (or Brain) Natriuretic Peptide Cause Decreased Plasma BNP Levels in Obese Heart Failure Patients?

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2019 Oct 29

PMID 31656800

Citations 3

Authors

Toshio Nishikimi

Yasuaki Nakagawa

Affiliations

Soon will be listed here.

Citing Articles

Current Understanding of Circulating Biomarkers in Pulmonary Hypertension Due to Left Heart Disease.

Todd N, Lai Y Front Med (Lausanne). 2020; 7:570016.

PMID: 33117832 PMC: 7575769. DOI: 10.3389/fmed.2020.570016.

Serum N-terminal Pro-B-type Natriuretic Peptide Predicts Mortality in Cardiac Surgery Patients Receiving Renal Replacement Therapy.

Su Y, Hou J, Zhang Y, Ma G, Hao G, Luo J Front Med (Lausanne). 2020; 7:153.

PMID: 32457914 PMC: 7225276. DOI: 10.3389/fmed.2020.00153.

ProBNP processing is decreased by obesity in patients with heart failure.

Lewis L, Raudsepp S, Prickett T, Yandle T, Pemberton C, Richards A Ann Transl Med. 2020; 8(4):135.

PMID: 32175428 PMC: 7049067. DOI: 10.21037/atm.2019.12.81.

References

Nishikimi T, Iemura-Inaba C, Akimoto K, Ishikawa K, Koshikawa S, Matsuoka H . Stimulatory and Inhibitory regulation of lipolysis by the NPR-A/cGMP/PKG and NPR-C/G(i) pathways in rat cultured adipocytes. Regul Pept. 2008; 153(1-3):56-63. DOI: 10.1016/j.regpep.2008.10.010. View

Nakagawa Y, Nishikimi T, Kuwahara K . Atrial and brain natriuretic peptides: Hormones secreted from the heart. Peptides. 2018; 111:18-25. DOI: 10.1016/j.peptides.2018.05.012. View

Halfinger B, Hammerer-Lercher A, Amplatz B, Sarg B, Kremser L, Lindner H . Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure. Clin Chem. 2017; 63(1):359-368. DOI: 10.1373/clinchem.2016.265397. View

Myhre P, Vaduganathan M, Claggett B, Packer M, Desai A, Rouleau J . B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial. J Am Coll Cardiol. 2019; 73(11):1264-1272. PMC: 7955687. DOI: 10.1016/j.jacc.2019.01.018. View

Daniels L, Maisel A . Natriuretic peptides. J Am Coll Cardiol. 2007; 50(25):2357-68. DOI: 10.1016/j.jacc.2007.09.021. View

Lewis L, Raudsepp S, Prickett T, Yandle T, Doughty R, Frampton C . ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased with Obesity in Patients with Heart Failure. Clin Chem. 2019; 65(9):1115-1124. DOI: 10.1373/clinchem.2019.302547. View

Kuwahara K, Nakagawa Y, Nishikimi T . Cutting Edge of Brain Natriuretic Peptide (BNP) Research　- The Diversity of BNP Immunoreactivity and Its Clinical Relevance. Circ J. 2018; 82(10):2455-2461. DOI: 10.1253/circj.CJ-18-0824. View

Nakagawa Y, Nishikimi T, Kuwahara K, Fujishima A, Oka S, Tsutamoto T . MiR30-GALNT1/2 Axis-Mediated Glycosylation Contributes to the Increased Secretion of Inactive Human Prohormone for Brain Natriuretic Peptide (proBNP) From Failing Hearts. J Am Heart Assoc. 2017; 6(2). PMC: 5523735. DOI: 10.1161/JAHA.116.003601. View

Semenov A, Postnikov A, Tamm N, Seferian K, Karpova N, Bloshchitsyna M . Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site. Clin Chem. 2009; 55(3):489-98. DOI: 10.1373/clinchem.2008.113373. View

10.

Kato K, Murakami H, Isozaki O, Tsushima T, Takano K . Serum concentrations of BNP and ANP in patients with thyrotoxicosis. Endocr J. 2008; 56(1):17-27. DOI: 10.1507/endocrj.k08e-145. View

11.

Takahama H, Takashio S, Nishikimi T, Hayashi T, Nagai-Okatani C, Nakagawa Y . Ratio of pro-B-type natriuretic peptide (BNP) to total BNP is decreased in mild, but not severe, acute decompensated heart failure patients: A novel compensatory mechanism for acute heart failure. Int J Cardiol. 2018; 258:165-171. DOI: 10.1016/j.ijcard.2017.12.047. View

12.

Omar H . Acute cardiogenic pulmonary edema with normal BNP: the value of repeat BNP testing. Am J Emerg Med. 2014; 33(4):605.e5-6. DOI: 10.1016/j.ajem.2014.10.006. View

13.

Nishikimi T, Minamino N, Ikeda M, Takeda Y, Tadokoro K, Shibasaki I . Diversity of molecular forms of plasma brain natriuretic peptide in heart failure--different proBNP-108 to BNP-32 ratios in atrial and ventricular overload. Heart. 2009; 96(6):432-9. DOI: 10.1136/hrt.2009.178392. View

14.

Vodovar N, Seronde M, Laribi S, Gayat E, Lassus J, Boukef R . Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure. Eur Heart J. 2014; 35(48):3434-41. DOI: 10.1093/eurheartj/ehu314. View

15.

Mehra M, Uber P, Park M, Scott R, Ventura H, Harris B . Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol. 2004; 43(9):1590-5. DOI: 10.1016/j.jacc.2003.10.066. View

16.

Mizuno Y, Harada E, Katoh D, Kashiwagi Y, Morikawa Y, Nakagawa H . Cardiac production of B-type natriuretic peptide is inversely related to the plasma level of free fatty acids in obese individuals - possible involvement of the insulin resistance -. Endocr J. 2012; 60(1):87-95. DOI: 10.1507/endocrj.ej12-0239. View

17.

Ozaki J, Shimizu H, Hashimoto Y, Itoh H, Nakao K, Inui K . Enzymatic inactivation of major circulating forms of atrial and brain natriuretic peptides. Eur J Pharmacol. 1999; 370(3):307-12. DOI: 10.1016/s0014-2999(99)00115-6. View

18.

Minai K, Komukai K, Arase S, Nagoshi T, Matsuo S, Ogawa K . Cardiac tamponade as an independent condition affecting the relationship between the plasma B-type natriuretic peptide levels and cardiac function. Heart Vessels. 2012; 28(4):510-3. DOI: 10.1007/s00380-012-0278-x. View

19.

Chefetz I, Sprecher E . Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis. Biochim Biophys Acta. 2008; 1792(9):847-52. PMC: 3169301. DOI: 10.1016/j.bbadis.2008.10.008. View

20.

Nishikimi T, Kuwahara K, Nakao K . Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides. J Cardiol. 2011; 57(2):131-40. DOI: 10.1016/j.jjcc.2011.01.002. View